Home›Companies›Biotech & Pharma›Oxbridge Clinical

Oxbridge Clinical Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 3, 2025·Suggest an edit

About Oxbridge Clinical

Oxbridge Clinical is a private company based in Boston, Massachusetts, incorporated in 2023 in Delaware. It has reported $4,500,000 raised in one offering on Form D since November 2025. Its chief executive is Guilio Deangeli.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 8, 2025Nov 3, 2025$4,500,000fully sold3$1.5MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Oxbridge Clinical's Form D filed Nov 3, 2025.

GD
Guilio Deangeli
CEO and director

Sources

  1. SECOxbridge Clinical Inc. filing history